Marrone Bio Innovations Inc sees revenue increase 14%, improves balance sheet in 1Q on strong biological crop protection sales
Marrone Bio sees 1Q revenue grow 14% on improved balance sheet amid strong biological crop protection sales The company attributed the revenue growth to “further market penetration” for its biological crop protection products, particularly driven by its Venerate, Grandevo and Regalia brands The global seed treatment market is forecasted to grow at approximately a 12% CAGR through 2025 Marrone Bio Innovations Inc (NASDAQ) reported its 11th consecutive growth quarter with revenues increasing 14% year-over-year to $11 million. The Davis, California-based group attributed the reve...
Source: proactiveinvestors.com